MicroRNA-944 Affects Cell Growth by Targeting EPHA7 in Non-Small Cell Lung Cancer.
MicroRNAs (miRNAs) have critical roles in lung tumorigenesis and development. To determine aberrantly expressed miRNAs involved in non-small cell lung cancer (NSCLC) and investigate pathophysiological functions and mechanisms, we firstly carried out small RNA deep sequencing in NSCLC cell lines (EPLC-32M1, A549 and 801D) and a human immortalized cell line 16HBE, we then studied miRNA function by cell proliferation and apoptosis. cDNA microarray, luciferase reporter assay and miRNA transfection were used to investigate interaction between the miRNA and target gene. miR-944 was significantly down-regulated in NSCLC and had many putative targets. Moreover, the forced expression of miR-944 significantly inhibited the proliferation of NSCLC cells in vitro. By integrating mRNA expression data and miR-944-target prediction, we disclosed that EPHA7 was a potential target of miR-944, which was further verified by luciferase reporter assay and microRNA transfection. Our data indicated that miR-944 targets EPHA7 in NSCLC and regulates NSCLC cell proliferation, which may offer a new mechanism underlying the development and progression of NSCLC.
Laboratory of Molecular and Experimental Pathology, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, China. L-M-X101@163.com.
Minxia
M
Liu
Laboratory of Molecular and Experimental Pathology, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, China. zhoukecheng1988@gmail.com.|Kunming College of Life Science, University of Chinese Academy of Sciences, Kunming 650223, China. zhoukecheng1988@gmail.com.
Kecheng
K
Zhou
Laboratory of Molecular and Experimental Pathology, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650223, China. caoy@mail.kiz.ac.cn.
Yi
Y
Cao
EPHA7; cell proliferation; miR-944; non-small cell lung cancer (NSCLC); regulation
Cancer Sci. 2015 Oct;106(10):1463-73
26177443
J Natl Compr Canc Netw. 2013 Jun 1;11(6):645-53; quiz 653
23744864
BMC Med Genomics. 2012 Sep 06;5:40
22954303
Oncogene. 2005 Aug 25;24(36):5637-47
16007213
Br J Cancer. 2010 Oct 12;103(8):1144-8
20859290
Cell Physiol Biochem. 2015;36(2):435-45
25968442
Lung Cancer. 2013 Sep;81(3):388-96
23756108
Cell. 2011 Oct 28;147(3):554-64
22036564
Nature. 2005 Feb 17;433(7027):769-73
15685193
Appl Immunohistochem Mol Morphol. 2004 Sep;12(3):240-7
15551738
Int J Cancer. 2009 Jan 1;124(1):88-94
18821581
EMBO Mol Med. 2012 Mar;4(3):143-59
22351564
Mol Biosyst. 2015 Jul;11(7):2051-9
25988292
World J Surg. 2012 Nov;36(11):2699-707
22851141
Cell. 2004 Jan 23;116(2):281-97
14744438
Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):E4288-97
26187928
BMC Cancer. 2008 Mar 25;8:79
18366728
Mayo Clin Proc. 2008 May;83(5):584-94
18452692
J Thorac Oncol. 2007 Apr;2(4):327-43
17409807
Hum Pathol. 2007 Nov;38(11):1649-56
17669470
Zhonghua Bing Li Xue Za Zhi. 2012 May;41(5):335-9
22883674
Mol Oncol. 2014 Oct;8(7):1208-19
24785186
BMC Clin Pathol. 2014 Feb 04;14(1):8
24495444
J Exp Clin Cancer Res. 2015 Oct 14;34:121
26467212
Mod Pathol. 2012 Mar;25(3):405-15
22056955
Mol Cancer. 2014 Nov 06;13:245
25373388
Brief Bioinform. 2009 Sep;10(5):490-7
19332473
Int J Cancer. 2013 Jul;133(1):67-78
23280316